Extended-spectrum beta-lactamases: the end of cephalosporins? | Isr Med Assoc J;7(5): 336-8, 2005 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Extended-spectrum beta-lactamases: the end of cephalosporins?

Colodner, Raul; Raz, Raul.

Isr Med Assoc J ; 7(5): 336-8, 2005 May.

Article in En | MEDLINE | ID: mdl-15909470

Subject(s)

Anti-Bacterial Agents; Bacteria/drug effects; Cephalosporin Resistance/physiology; Cephalosporins; beta-Lactamases; Anti-Bacterial Agents/pharmacology; Cephalosporins/pharmacology; Humans; Israel; Risk Factors; beta-Lactamases/biosynthesis; beta-Lactamases/drug effects

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bacteria / Beta-Lactamases / Cephalosporins / Cephalosporin Resistance / Anti-Bacterial Agents Type of study: Etiology_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Isr Med Assoc J Journal subject: MEDICINA Year: 2005 Document type: Article Country of publication: Israel

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Bacteria / Beta-Lactamases / Cephalosporins / Cephalosporin Resistance / Anti-Bacterial Agents Type of study: Etiology_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Isr Med Assoc J Journal subject: MEDICINA Year: 2005 Document type: Article Country of publication: Israel